Natalie Kinloch

Ms. Natalie Kinloch


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Viruses
Verified
Journal Article
Open access
PDF file
BTBirkneh Tilahun Tadesse
Birkneh Tilahun Tadesse
NKNatalie Kinloch
Natalie Kinloch
BBBemulu Baraki
Bemulu Baraki
HLHope R. Lapointe
Hope R. Lapointe
KCKyle D. Cobarrubias
Kyle D. Cobarrubias
ZBZabrina L Brumme
Zabrina L Brumme
Clinical monitoring of pediatric HIV treatment remains a major challenge in settings where drug resistance genotyping is not routinely available. As a result, our understanding of drug resistance, and its impact on subsequent therapeutic regimens available in these settings, remains limited. We investigate the prevalence and correlates of HIV-1 drug resistance among 94 participants of the Ethiopia Pediatric HIV Cohort failing first-line combination antiretroviral therapy (cART) using dried blood spot-based genotyping. Overall, 81% (73/90) of successfully genotyped participants harbored resistance mutations, including 69% (62/90) who harbored resistance to both Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs). Strikingly, 42% of resistant participants harbored resistance to all four NRTIs recommended for second-line use in this setting, meaning that there are effectively no remaining cART options for these children. Longer cART duration and prior regimen changes were significantly associated with detection of drug resistance mutations. Replicate genotyping increased the breadth of drug resistance detected in 34% of cases, and thus is recommended for consideration when typing from blood spots. Implementation of timely drug resistance testing and access to newer antiretrovirals and drug classes are urgently needed to guide clinical decision-making and improve outcomes for HIV-infected children on first-line cART in Ethiopia.

8 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
NKNatalie Kinloch
Natalie Kinloch
GRGordon Ritchie
Gordon Ritchie
CBChanson J Brumme
Chanson J Brumme
WDWinnie Dong
Winnie Dong
WDWeiyan Dong
Weiyan Dong
ZBZabrina L Brumme
Zabrina L Brumme
Improper nasopharyngeal swab collection could contribute to false-negative COVID-19 results. In support of this, specimens from confirmed or suspected COVID-19 cases that tested negative or indeterminate ( i.e. suspected false-negatives) contained less human DNA (a stable molecular marker of sampling quality) compared to a representative pool of specimens submitted for testing.

25 August 2020 in medRxiv
Verified
Preprint
Open access
PDF file
NKNatalie Kinloch
Natalie Kinloch
ASAniqa Shahid
Aniqa Shahid
GRGordon Ritchie
Gordon Ritchie
WDWinnie Dong
Winnie Dong
TLTanya Lawson
Tanya Lawson
Victor C. M. LeungVictor C. M. Leung
Victor C. M. Leung
Nasopharyngeal swabs are critical to the diagnosis of respiratory infections including COVID-19, but collection techniques vary. We compared two recommended nasopharyngeal swab collection techniques in adult volunteers and found that swab rotation following nasopharyngeal contact did not recover additional nucleic acid (as measured by human DNA/RNA copy number). Rotation was also less tolerable for participants. Notably, both discomfort and nucleic acid recovery were significantly higher in Asians, consistent with nasal anatomy differences. Our results suggest that it is unnecessary to rotate the swab in place following contact with the nasopharynx, and reveal that procedural discomfort levels can differ by ethnicity. summary: Nasopharyngeal swabs are critical to COVID-19 diagnostics, but collection techniques vary. Comparison of two collection techniques revealed that swab rotation did not recover more nucleic acid and was more uncomfortable. Discomfort and biological material recovery also varied by participant ethnicity.